The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph‐like ALL
Open Access
- 5 February 2024
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 28 (3) , e18114
Abstract
Patients with Philadelphia chromosome‐like acute lymphoblastic leukaemia (Ph‐like ALL) often face a grim prognosis, with PDGFRB gene fusions being commonly detected in this subgroup. Our study has unveiled a newfound fusion gene, TERF2::PDGFRB, and we have found that patients carrying this fusion gene exhibit sensitivity to dasatinib. Ba/F3 cells harbouring the TERF2::PDGFRB fusion display IL‐3‐independent cell proliferation through activation of the p‐PDGFRB and p‐STAT5 signalling pathways. These cells exhibit reduced apoptosis and demonstrate sensitivity to imatinib in vitro. When transfused into mice, Ba/F3 cells with the TERF2::PDGFRB fusion gene induce tumorigenesis and a shortened lifespan in cell‐derived graft models, but this outcome can be improved with imatinib treatment. In summary, we have identified the novel TERF2::PDGFRB fusion gene, which exhibits oncogenic potential both in vitro and in vivo, making it a potential therapeutic target for tyrosine kinase inhibitors (TKIs).Keywords
This publication has 28 references indexed in Scilit:
- Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALLBlood Advances, 2017
- Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemiaLeukemia, 2017
- High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in AdultsJournal of Clinical Oncology, 2017
- Platelet-derived growth factor receptors (PDGFRs) fusion genes involvement in hematological malignanciesCritical Reviews in Oncology/Hematology, 2017
- Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2014
- Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinibBlood, 2014
- Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA,PDGFRB, and FGFR1: a reviewInternational Journal of Laboratory Hematology, 2013
- Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET ProjectBlood, 2013
- New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinasesBlood, 2010
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification studyThe Lancet Oncology, 2009